The Third Survey of Prescription Pattern of Psychotropic... | NCT01668810

Studies
The Third Survey of Prescription Pattern of Psychotropic Drugs in China

NCT01668810

Sponsor

Peking University

Status

Unknown status

Last Update Posted

Aug 20, 2012Estimated

Enrollment

7,000Estimated

Phase

Not provided

Conditions

Prescription

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jul 2012

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jul 2012

Primary Completion Date

Sep 2012Estimated

Completion Date

Jul 2013Estimated

First Submitted Date

Aug 16, 2012

First Submission Date that Met QC Criteria

Aug 17, 2012

First Posted Date

Aug 20, 2012Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Aug 17, 2012

Last Update Posted Date

Aug 20, 2012Estimated

Name	Class
Xian-Janssen Pharmaceutical Ltd.	INDUSTRY

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

7,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Beijing region		include six hospitals
Guangdong Province		include 3 hospitals
Jiangsu province		include 3 hospitals
Hebei province		include 6 hospitals
Hubei Province		include 7 hospitals
Shanxi province		include 3 hospitals
Jiangxi province		include 3 hospitals
Jilin province		include 6 hospitals

Interventions

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria: aged 18-65, inpatient or outpatient, Patient must be willing and able to give written informed consent,the patient suffers from schizophrenia or depression or bipolar disorder -

Exclusion Criteria:aged<18or aged>65

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

65 Years

Standard Ages

AdultOlder Adult

Study Population

schizophrenia, depression and bipolar disorder patients

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Yun-Ai Su, Phd.	Contact	8610-82801960		suyunai@gmail.com

Overall Officials

Name	Affiliation	Role
Xin Yu, MD.	Peking University	Study Chair

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Institute of mental health, Peking University	Recruiting	Beijing	Beijing Municipality	100191	China

Condition Browse Module

MeSH Terms

ID	Term
D012559	Schizophrenia
D003863	Depression
D001714	Bipolar Disorder

Ancestor Terms

ID	Term
D019967	Schizophrenia Spectrum and Other Psychotic Disorders
D001523	Mental Disorders
D001526	Behavioral Symptoms
D001519	Behavior

Browse Leaves

Not provided

Browse Branches

Not provided